Lactate

ApprovedSmall molecule

RRutgers, The State University of New Jersey

Lactate is one of 108 small molecule programs targeting Ischemia. It is currently in Approved.

Indications

Total Trials

Active Trials

107

Competitors

Pipeline

Status by Indication[3][1]

Indication

IschemiaActive, not recruiting

HypoglycemiaActive, not recruiting

Ischemic StrokeActive, not recruiting

IschemiaPhase 1

Active, not recruiting

HypoglycemiaApproved

Active, not recruiting

Ischemic StrokePhase 2

Active, not recruiting

Competition

Competitive Landscape

430 competitors in Ischemic Stroke

#DrugCompanyPhaseTrials

Lactate

RRutgers, The State University of New Jersey

Approved

1 2

Proamatine

Takeda

Preclinical

2 3

Repatha

Amgen

Preclinical

2 4

Levaquin

WWim Janssens

Preclinical

3 5

Tylenol

KKenvue Brands

Preclinical

1 6

Xylocaine

CCitius Pharmaceuticals, Inc.

Preclinical

1 7

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

1 8

Statins

Sanofi

Preclinical

1 9

Urokinase

Mmedac GmbH

Preclinical

3 10

Drug Therapy

MMassachusetts General Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2030

N/ANot yet recruiting

Study completion

NCT06955130

Phase 1Not yet recruiting

Ischemia

NCT06825143

Clinical

Trials by Indication[1]

Hypoglycemia1 trial

Lactate to Treat Hypoglycemia

Withdrawn·IInstitut d'Anesthesiologie des Alpes Maritimes·Phase 4·NCT01387477

Ischemia1 trial

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury

Not yet recruiting·GGary Van Guilder·Phase 1·NCT06825143·68 enrolled

Ischemic stroke1 trial

Exploring the Effect of Lactate Administration After Ischemic Stroke on Brain Metabolism

Terminated·—·Phase 2·NCT04858139·28 enrolled

Unspecified1 trial

Lactate and Glycerol Contribution to Gluconeogenesis

Not yet recruiting·RRutgers, The State University of New Jersey·N/A·NCT06955130·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Lactate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lactate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lactate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Rutgers, The State University of New Jersey company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: RRutgers, The State University of New Jersey

Lactate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2030

Trials by Indication[1]

Hypoglycemia1 trial

Ischemia1 trial

Ischemic stroke1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News